Website stats and analysis

Copyright MEDICINOVA, Inc. All Right Reserverd.

2.48 Rating by Usitestat

medicinova.jp was registered 1 decade 8 years ago. It has a alexa rank of #1,734,148 in the world. It is a domain having .jp extension. It is estimated worth of $ 720.00 and have a daily income of around $ 3.00. As no active threats were reported recently, medicinova.jp is SAFE to browse.

Traffic Report

Daily Unique Visitors: 506
Daily Pageviews: 1,012

Estimated Valuation

Income Per Day: $ 3.00
Estimated Worth: $ 720.00

Search Engine Indexes

Google Indexed Pages: Not Applicable
Yahoo Indexed Pages: Not Applicable
Bing Indexed Pages: Not Applicable

Search Engine Backlinks

Google Backlinks: Not Applicable
Bing Backlinks: Not Applicable
Alexa BackLinks: Not Applicable

Safety Information

Google Safe Browsing: No Risk Issues
Siteadvisor Rating: Not Applicable
WOT Trustworthiness: Very Poor
WOT Privacy: Very Poor
WOT Child Safety: Very Poor

Website Ranks & Scores

Alexa Rank: 1,734,148
PageSpeed Score: 89 ON 100
Domain Authority: 49 ON 100
Bounce Rate: Not Applicable
Time On Site: Not Applicable

Web Server Information

Hosted IP Address:

183.90.231.41

Hosted Country:

Japan JP

Location Latitude:

34.733

Location Longitude:

135.4

Traffic Classification

Total Traffic: No Data
Direct Traffic: No Data
Referral Traffic: No Data
Search Traffic: No Data
Social Traffic: No Data
Mail Traffic: No Data
Display Traffic: No Data

Search Engine Results For medicinova.jp

MNOV.A - MediciNova, Inc. Profile | Reuters

- https://www.reuters.com/companies/MNOV.A

4 days ago ... MediciNova, Inc. is a biopharmaceutical company. The Company is focused on developing novel therapeutics for the treatment of serious diseases ...


MediciNova, Inc. (MNOV) Stock Price, News, Quote & History

- https://finance.yahoo.com/quote/MNOV/

Find the latest MediciNova, Inc. (MNOV) stock quote, history, news and other vital information to help you with your stock trading and investing.


4875.T-JP: MediciNova Inc - Stock Price, Quote and News - CNBC

- https://www.cnbc.com/quotes/4875.T-JP

Get MediciNova Inc (4875.T-JP:Tokyo Stock Exchange) real-time stock quotes, news, price and financial information from CNBC.


Medicinova Inc Common Stock (MNOV) - Nasdaq

- https://www.nasdaq.com/market-activity/stocks/mnov

MediciNova Inc is a biopharmaceutical company. It acquires and develops small-molecule therapeutics for the treatment of diseases with unmet medical needs ...


MediciNova Inc. Stock Quote (JASDAQ) - Investing - MarketWatch

- https://www.marketwatch.com/investing/stock/4875?countrycode=jp

MediciNova Inc. Watchlist. 4875JP. Closed. Back To Top. Last Updated ...


MediciNova Announces Positive FDA Feedback to Start Phase III ...

- http://web.alsa.org/site/PageNavigator/blog_092618.html

Over 20 years ago, ibudilast was approved in Japan to treat post-stroke complications and asthma. Leadership at MediciNova plan to move the phase III trial ...


Designation of Securities Under Supervision (Confirmation)

- https://www.jpx.co.jp/english/news/1021/20201228-01.html

Dec 28, 2020 ... Japan Exchange Group (JPX) offers a one-stop shop for a range of products ... Reason, MediciNova, Inc. (hereinafter "the Company") has been ...


Jobs with MediciNova, Inc. - BioSpace

- https://www.biospace.com/employer/527171/medicinova-inc-/

jobs with MediciNova, Inc. to view and apply for now with BioSpace. ... and Riluzole for the Treatment of Amyotrophic Lateral Sclerosis (ALS) in Japan.


Ibudilast - MediciNova - AdisInsight

- https://adisinsight.springer.com/drugs/800003982

Oral ibudilast has been launched in Japan as Ketas® by Kyorin Pharmaceutical as an anti-asthmatic agent. Allergic conjunctivitis. Ibudilast has been launched in ...


メディシノバ・インク 東京事務所 (@MedicinovaJapan) | Twitter

- https://twitter.com/medicinovajapan

メディシノバは、十分な治療がまだ確立していない疾病を伴う患者さんに、よりよい ... 年9月30日号) (link: https://qr.paps.jp/Zo972 ) #メディシノバ #Medicinova.


メディシノバ

- https://medicinova.jp/

メディシノバは、新規性のある治療薬のグローバル開発・販売に特化した製薬企業です。


Medicinova (4875) - Credit Suisse | PLUS

- https://plus.credit-suisse.com/rpc4/ravDocView?docid=V6A35B2AK-e

Apr 18, 2017 ... 18 April 2017. Asia Pacific/Japan. Equity Research. Biotechnology (Biotechnology (Japan)). Medicinova (4875). INITIATION. Rating. OUTPERFORM.


Evaluation of MN-166 (Ibudilast) for 12 Months Followed by an Open ...

- https://clinicaltrials.gov/ct2/show/NCT04057898

Aug 15, 2019 ... MediciNova. Information provided by (Responsible Party):. MediciNova. Study Details; Tabular View · No Results Posted · Disclaimer ...


MN-001 - For The Treatment of Interstitial Cystitis - MediciNova

- https://medicinova.com/clinical-development/non-core/mn-001-ic/medicinova-approach/

MN-001 produced anti-inflammatory effects in a variety of rodent models of IC and asthma; in these models, MN-001 reduced bladder hyper-reactivity much in the ...


MediciNova, Inc.×モーニングスター 特別対談 - YouTube

- https://www.youtube.com/watch?v=qGdI7qOy54A

MediciNova, Inc.×モーニングスター 特別対談~メディシノバの現状と今後の事業展望~MediciNova, Inc.(メディシノバ)代表取締役社長兼CEO 岩城 裕一 ...


MediciNova Inc. - AnnualReports.com

- https://www.annualreports.com/Company/medicinova-inc

MediciNova, Inc., a biopharmaceutical company, engages in the acquisition and development of small-molecule therapeutics for the treatment of serious diseases ...


Joint press release of MediciNova, Inc. and Avigen, Inc - SEC.gov

- https://www.sec.gov/Archives/edgar/data/1226616/000119312509258117/dex991.htm

MEDICINOVA AND AVIGEN STOCKHOLDERS APPROVE MERGER. SAN DIEGO, Calif., and ALAMEDA, Calif., December 17, 2009 — MediciNova, Inc., a biopharmaceutical company ...


MediciNova Reports Second Quarter 2021 Financial Results

- https://www.globenewswire.com/news-release/2021/08/12/2280218/7767/en/MediciNova-Reports-Second-Quarter-2021-Financial-Results-and-Business-Update.html

Aug 12, 2021 ... MediciNova, Inc. is a clinical-stage biopharmaceutical company developing a broad late-stage pipeline of novel small molecule therapies for ...


MediciNova to Participate in the Morgan Stanley 19th Annual

- https://www.globenewswire.com/news-release/2021/09/03/2291245/7767/en/MediciNova-to-Participate-in-the-Morgan-Stanley-19th-Annual-Global-Healthcare-Conference.html

Sep 2, 2021 ... LA JOLLA, Calif., Sept. 02, 2021 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market ...


MediciNova, Inc. (MNOV) Stock Price & News - Google Finance

- https://www.google.com/finance/quote/MNOV:NASDAQ

Get the latest MediciNova, Inc. (MNOV) real-time quote, historical performance, charts, and other financial information to help you make more informed ...


MNOV | MediciNova Inc. Stock Price & News - WSJ

- https://www.wsj.com/market-data/quotes/MNOV/options

MediciNova Inc. options quotes data for sells and puts, including MNOV last price, change and volume.

Page Resources Breakdown

Homepage Links Analysis

メディシノバは、新規性のある治療薬のグローバル開発・販売に特化した製薬企業です。

Website Inpage Analysis

H1 Headings: 4 H2 Headings: 6
H3 Headings: Not Applicable H4 Headings: Not Applicable
H5 Headings: Not Applicable H6 Headings: Not Applicable
Total IFRAMEs: Not Applicable Total Images: 34
Google Adsense: Not Applicable Google Analytics: UA-110228973-1

Two Phrase Analysis

Words Occurrences Density Possible Spam
IRニュース メディアイベント 3 2.609 % No
研究開発 IRニュース 3 2.609 % No
IRスケジュール アナリスト情報一覧 2 1.739 % No
決算短信 有価証券報告書 2 1.739 % No
株式情報 IRスケジュール 2 1.739 % No
株主・投資家のみなさまへ IRニュース 2 1.739 % No
有価証券報告書 四半期報告書 2 1.739 % No
IRニュース 財務情報 2 1.739 % No
株主総会資料 株主通信 2 1.739 % No
学会発表・論文関連資料 動画 2 1.739 % No
English 検索 2 1.739 % No
決算説明会資料 学会発表・論文関連資料 2 1.739 % No
株主通信 決算説明会資料 2 1.739 % No
クラッベ病 DCM(変性性頸椎脊椎症) 2 1.739 % No
四半期報告書 株主総会資料 2 1.739 % No
IRライブラリー 決算短信 2 1.739 % No
トップメッセージ 理念・経営方針 2 1.739 % No
会社概要 経営メンバー 2 1.739 % No
企業情報 トップメッセージ 2 1.739 % No
メディアイベント 企業情報 2 1.739 % No

Four Phrase Analysis

Words Occurrences Density Possible Spam
詳しくはこちらから Page Top お問い合わせ 1 0.87 % No
Page Top お問い合わせ よくあるご質問 1 0.87 % No
約0兆円 詳しくはこちらから Page Top 1 0.87 % No
KEY NUMBER ファストトラック指定 0本 1 0.87 % No
IR INFORMATION KEY NUMBER 1 0.87 % No
INFORMATION KEY NUMBER ファストトラック指定 1 0.87 % No
ご利用条件 東京事務所BLOG Copyright © 1 0.87 % No
東京事務所BLOG Copyright © 2021 1 0.87 % No
MEDICINOVA Inc All Right 1 0.87 % No
Inc All Right Reserverd 1 0.87 % No
2021 MEDICINOVA Inc All 1 0.87 % No
© 2021 MEDICINOVA Inc 1 0.87 % No
Copyright © 2021 MEDICINOVA 1 0.87 % No
20210622 メディア Maxim Group 1 0.87 % No
20210623 メディア Zacks SmallCap 1 0.87 % No
アナリスト情報一覧 English 検索 × 1 0.87 % No
メディアイベント 20211021 MN001学会 第19回 1 0.87 % No
MN221 気管支喘息急性発作 MN029 固形がん 1 0.87 % No
動画 ニュース 研究開発 IRニュース 1 0.87 % No
検索 ニュース 研究開発 IRニュース 1 0.87 % No

HTTP Header Analysis

Http-Version: 1.1
Status-Code: 200
Status: 200 OK
Server: nginx
Date: Fri, 22 Oct 2021 07:41:15 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Vary: Accept-Encoding
Link: ; rel="https://api.w.org/"
Content-Encoding: gzip

Domain Information

Domain Registrar: Japan Registry Services
Registration Date: 2006-04-07 1 decade 8 years 7 months ago
Last Modified: 2021-08-27 3 years 2 months 3 weeks ago
Expiration Date: 2022-04-30 2 years 6 months 3 weeks ago
Owner's E-Mail: [email protected]

Domain Nameserver Information

Host IP Address Country
ns1.xbiz.ne.jp 157.112.182.247 Japan Japan
ns2.xbiz.ne.jp 35.76.79.244 United States United States
ns3.xbiz.ne.jp 157.112.191.237 Japan Japan

DNS Record Analysis

Host Type TTL Extra
medicinova.jp A 3593 IP: 183.90.231.41
medicinova.jp NS 3600 Target: ns1.xbiz.ne.jp
medicinova.jp NS 3600 Target: ns3.xbiz.ne.jp
medicinova.jp NS 3600 Target: ns2.xbiz.ne.jp
medicinova.jp SOA 3600 MNAME: ns1.xbiz.ne.jp
RNAME: root.xbiz.ne.jp
Refresh: 10800
Retry: 3600
Expire: 604800
medicinova.jp MX 3600 Target: medicinova.jp
medicinova.jp TXT 3600 TXT: v=spf1 +a:sv240.xbiz.ne.jp
+a:medicinova.jp +mx ~all

Full WHOIS Lookup

[ JPRS database provides information on network administration. Its
use is ]
[ restricted to network administration purposes. For
further information, ]
[ use 'whois -h whois.jprs.jp help'. To
suppress Japanese output, add'/e' ]
[ at the end of command, e.g.
'whois -h whois.jprs.jp xxx/e'. ]

Domain
Information:
[Domain Name] MEDICINOVA.JP

[Registrant]
MediciNova., Inc.

[Name Server] ns1.xbiz.ne.jp
[Name
Server] ns2.xbiz.ne.jp
[Name Server] ns3.xbiz.ne.jp
[Signing
Key]

[Created on] 2006/04/07
[Expires on]
2022/04/30
[Status] Active
[Last Updated] 2021/08/27 14:23:03
(JST)

Contact Information:
[Name] MediciNova.,
Inc.
[Email] [email protected]
[Web Page]
[Postal
code] 105-0003
[Postal Address] Minato-ku
1-11-5
Nishi-Shibashi
Level5, Shinbashi Chuo Building
[Phone]
03-3519-5010
[Fax] 03-3593-2721

Similarly Ranked Websites

Kpop merch, hoodies, and Korean style apparel | Kpoptify.com

- thekpoptify.co

Largest selection of Kpop merch, hoodies, and more for your favorite groups and Korean style apparel. Get fast shipping and good prices at Kpoptify.

1,734,177   $ 720.00

CIL - Canada's Interior Paints & Exterior Paints & Stains | CIL.CA

- cil.ca

Canada's favorite brand of decorative paints has been sold by leading retailers and dealers for over 75 years. A PPG Architectural Coatings Canada brand.

1,734,193   $ 720.00

Rose Theatre Kingston

- rosetheatrekingston.org

1,734,215   $ 720.00

KnowledgeForce

- knowledgeforce.com

1,734,219   $ 720.00

藤元メディカルシステム

- fujimoto.or.jp

「医療」「介護」「健康」「教育」「社会貢献」を事業の柱として地域の皆様と共に歩んでいきます。

1,734,240   $ 720.00